Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Naama Rozen & Idan M. Aderka. (2022) The effect of depression on treatment outcome in social anxiety disorder: an individual-level meta-analysis. Cognitive Behaviour Therapy 51:3, pages 185-216.
Read now
Read now
Antoine Pelissolo, Sandra Abou Kassm & Lauriane Delhay. (2019) Therapeutic strategies for social anxiety disorder: where are we now?. Expert Review of Neurotherapeutics 19:12, pages 1179-1189.
Read now
Read now
Lisa Lampe & Gin S Malhi. (2018) Avoidant personality disorder: current insights. Psychology Research and Behavior Management 11, pages 55-66.
Read now
Read now
Mafalda M. Dias. (2018) Pharmacotherapy for Social Anxiety Disorder. Issues in Mental Health Nursing 39:12, pages 1047-1048.
Read now
Read now
Paweł Kawalec, Agnieszka Cierniak, Andrzej Pilc & Gabriel Nowak. (2015) Pregabalin for the treatment of social anxiety disorder. Expert Opinion on Investigational Drugs 24:4, pages 585-594.
Read now
Read now
Franklin R Schneier. (2011) Pharmacotherapy of social anxiety disorder. Expert Opinion on Pharmacotherapy 12:4, pages 615-625.
Read now
Read now
Articles from other publishers (39)
Alice Caldiroli, Enrico Capuzzi, Letizia Affaticati, Teresa Surace, Carla Di Forti, Antonios Dakanalis, Massimo Clerici & Massimiliano Buoli. (2023) Candidate Biological Markers for Social Anxiety Disorder: A Systematic Review. International Journal of Molecular Sciences 24:1, pages 835.
Crossref
Crossref
Natalia Duque-Wilckens, Lisette Y. TorresSae Yokoyama, Vanessa A. MinieAmy M. Tran, Stela P. PetkovaRebecca HaoStephanie Ramos-MacielRoberto A. RiosKenneth JacksonFrancisco J. Flores-RamirezIsrael Garcia-CarachurePatricia A. PesaventoSergio D. Iñiguez, Valery Grinevich & Brian C. Trainor. (2020) Extrahypothalamic oxytocin neurons drive stress-induced social vigilance and avoidance. Proceedings of the National Academy of Sciences 117:42, pages 26406-26413.
Crossref
Crossref
Naama Rozen & Idan M. Aderka. (2020) Do depressive symptoms affect the outcome of treatments for SAD? A meta analysis of randomized controlled trials. Clinical Psychology Review 80, pages 101874.
Crossref
Crossref
Samara M. Miller, Daniele Marcotulli, Angela Shen & Larry S. Zweifel. (2019) Divergent medial amygdala projections regulate approach–avoidance conflict behavior. Nature Neuroscience 22:4, pages 565-575.
Crossref
Crossref
Alexander G. Doruyter, Patrick Dupont, Dan J. Stein, Christine Lochner & James M. Warwick. (2018) Nuclear Neuroimaging in Social Anxiety Disorder: A Review. Journal of Nuclear Medicine 59:12, pages 1794-1800.
Crossref
Crossref
Gavin Andrews, Caroline Bell, Philip Boyce, Christopher Gale, Lisa Lampe, Omar Marwat, Ronald Rapee & Gregory Wilkins. (2018) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry 52:12, pages 1109-1172.
Crossref
Crossref
Mark D. Muse & Stephen M. Stahl. 2017. Cognitive Behavioral Psychopharmacology. Cognitive Behavioral Psychopharmacology
107
135
.
René Garcia. (2017) Neurobiology of fear and specific phobias. Learning & Memory 24:9, pages 462-471.
Crossref
Crossref
Falk Leichsenring & Frank Leweke. (2017) Social Anxiety Disorder. New England Journal of Medicine 376:23, pages 2255-2264.
Crossref
Crossref
Katharina Domschke, Hans-Peter Kapfhammer & Jürgen Deckert. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1857
1932
.
Elham Ahmadian, Hossein Babaei, Alireza Mohajjel Nayebi, Aziz Eftekhari & Mohammad Ali Eghbal. (2016) Venlafaxine-Induced Cytotoxicity Towards Isolated Rat Hepatocytes Involves Oxidative Stress and Mitochondrial/Lysosomal Dysfunction. Advanced Pharmaceutical Bulletin 6:4, pages 521-530.
Crossref
Crossref
Katharina Domschke, Hans-Peter Kapfhammer & Jürgen Deckert. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
77
.
Ifigeneia Mavranezouli, Evan Mayo-Wilson, Sofia Dias, Kayleigh Kew, David M. Clark, A. E. Ades & Stephen Pilling. (2015) The Cost Effectiveness of Psychological and Pharmacological Interventions for Social Anxiety Disorder: A Model-Based Economic Analysis. PLOS ONE 10:10, pages e0140704.
Crossref
Crossref
Jon E. Grant & Brian L. Odlaug. 2015. Anxiety Disorders and Gender. Anxiety Disorders and Gender
155
168
.
Franklin Schneier & Julia Goldmark. 2015. Anxiety Disorders and Gender. Anxiety Disorders and Gender
49
67
.
Evan Mayo-Wilson, Sofia Dias, Ifigeneia Mavranezouli, Kayleigh Kew, David M Clark, A E Ades & Stephen Pilling. (2014) Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. The Lancet Psychiatry 1:5, pages 368-376.
Crossref
Crossref
Susan M. Bögels, Paul Wijts, Frans J. Oort & Steph J. M. Sallaerts. (2014) PSYCHODYNAMIC PSYCHOTHERAPY VERSUS COGNITIVE BEHAVIOR THERAPY FOR SOCIAL ANXIETY DISORDER: AN EFFICACY AND PARTIAL EFFECTIVENESS TRIAL. Depression and Anxiety 31:5, pages 363-373.
Crossref
Crossref
Amy J Morgan, Anthony F Jorm & Nicola J Reavley. (2013) Beliefs of Australian health professionals about the helpfulness of interventions for mental disorders: Differences between professions and change over time. Australian & New Zealand Journal of Psychiatry 47:9, pages 840-848.
Crossref
Crossref
Jair de Jesus Mari, Luís Fernando Tófoli, Cristiano Noto, Li M. Li, Alessandra Diehl, Angélica M. Claudino & Mario F. Juruena. (2013) Pharmacological and Psychosocial Management of Mental, Neurological and Substance Use Disorders in Low- and Middle-Income Countries: Issues and Current Strategies. Drugs 73:14, pages 1549-1568.
Crossref
Crossref
Katherine Sorsdahl, Carlos Blanco, Donald S. Rae, Harold Pincus, William E. Narrow, Sharain Suliman & Dan J. Stein. (2013) Treatment of anxiety disorders by psychiatrists from the American Psychiatric Practice Research Network. Revista Brasileira de Psiquiatria 35:2, pages 136-141.
Crossref
Crossref
Franklin R. Schneier. 2012. Psychobiological Approaches for Anxiety Disorders. Psychobiological Approaches for Anxiety Disorders
41
60
.
Lawrence David Scahill. 2012. Pharmacotherapy of Child and Adolescent Psychiatric Disorders. Pharmacotherapy of Child and Adolescent Psychiatric Disorders
341
364
.
Ju-Yu YenCheng-Fang YenCheng-Sheng ChenPeng-Wei WangYi-Hsin ChangChih-Hung Ko. (2012) Social Anxiety in Online and Real-Life Interaction and Their Associated Factors. Cyberpsychology, Behavior, and Social Networking 15:1, pages 7-12.
Crossref
Crossref
Michelle N. Levitan, Marcos H. N. Chagas, José A. S. Crippa, Gisele G. Manfro, Luiz A. B. Hetem, Nathalia C. Andrada, Giovanni A. Salum, Luciano Isolan, Maria C. F. Ferrari & Antonio E. Nardi. (2011) Diretrizes da Associação Médica Brasileira para o tratamento do transtorno de ansiedade social. Revista Brasileira de Psiquiatria 33:3, pages 292-302.
Crossref
Crossref
Ulrich Stangier, Elisabeth Schramm, Thomas Heidenreich, Matthias Berger & David M. Clark. (2011) Cognitive Therapy vs Interpersonal Psychotherapy in Social Anxiety Disorder. Archives of General Psychiatry 68:7, pages 692.
Crossref
Crossref
Gabriela Bezerra de Menezes, Evandro Silva Freire Coutinho, Leonardo F. Fontenelle, Paula Vigne, Ivan Figueira & Márcio Versiani. (2010) Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials. Psychopharmacology 215:1, pages 1-11.
Crossref
Crossref
H.-P. Kapfhammer. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1702
1773
.
Naseema Cassimjee, Jean-Pierre Fouche, Michael Burnett, Christine Lochner, James Warwick, Patrick Dupont, Dan J. Stein, Karen J. Cloete & Paul D. Carey. (2010) Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram. Metabolic Brain Disease 25:4, pages 369-374.
Crossref
Crossref
Marcos Hortes N. Chagas, Antonio E. Nardi, Gisele G. Manfro, Luiz Alberto B. Hetem, Nathalia C. Andrada, Michelle N. Levitan, Giovanni A. Salum, Luciano Isolan, Maria Cecília Freitas Ferrari & José Alexandre S. Crippa. (2010) Diretrizes da Associação Médica Brasileira para o diagnóstico e diagnóstico diferencial do transtorno de ansiedade social. Revista Brasileira de Psiquiatria 32:4, pages 444-452.
Crossref
Crossref
Richard C Oude Voshaar, G J Hendriks, G Keijsers & Anton J van Balkom. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Franklin Schneier, Kristin Pontoski & Richard G. Heimberg. 2010. Anxiety Disorders. Anxiety Disorders
260
270
.
. 2010. Anxiety Disorders. Anxiety Disorders
249
361
.
Inna E. Tchivileva, Pei Feng Lim, Shad B. Smith, Gary D. Slade, Luda Diatchenko, Samuel A. McLean & William Maixner. (2010) Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study. Pharmacogenetics and Genomics 20:4, pages 239-248.
Crossref
Crossref
Lakshmi N. Ravindran, Daniel S. Kim, Andrea M. Letamendi & Murray B. Stein. (2009) A Randomized Controlled Trial of Atomoxetine in Generalized Social Anxiety Disorder. Journal of Clinical Psychopharmacology 29:6, pages 561-564.
Crossref
Crossref
P. Zwanzger, J. Diemer & B. Jabs. (2008) Comparison of combined psycho- and pharmacotherapy with monotherapy in anxiety disorders: controversial viewpoints and clinical perspectives. Journal of Neural Transmission 116:6, pages 759-765.
Crossref
Crossref
Richard C Oude Voshaar, G J Hendriks, G Keijsers & Anton J van Balkom. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Karleyton C Evans, Naomi M Simon, Darin D Dougherty, Elizabeth A Hoge, John J Worthington, Candice Chow, Rebecca E Kaufman, Andrea L Gold, Alan J Fischman, Mark H Pollack & Scott L Rauch. (2008) A PET Study of Tiagabine Treatment Implicates Ventral Medial Prefrontal Cortex in Generalized Social Anxiety Disorder. Neuropsychopharmacology 34:2, pages 390-398.
Crossref
Crossref
Keith A. Ganasen & Dan J. Stein. 2010. Behavioral Neurobiology of Anxiety and Its Treatment. Behavioral Neurobiology of Anxiety and Its Treatment
487
503
.
C. François, S. A. Montgomery, N. Despiegel, S. Aballéa, J. Roïz & P. Auquier. (2008) Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder. International Journal of Clinical Practice 62:11, pages 1693-1702.
Crossref
Crossref